In conclusion, this study constructed a novel inflammation-immune model containing AST, CRP, and lymphocyte count, which not only could effectively predict prognosis and MRD for patients with HCC after curative resection but also might guide the clinical decision of optimal resection margin. Here, CRP is linked to hepatocellular carcinoma.